Clinical Trial Update: NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL [NA]

View source ↗

Summary

This document describes a planned clinical trial to evaluate minimal residual disease-guided treatment with blinatumomab for pediatric B cell precursor acute ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Precursor Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: B Cell Precursor Acute Lymphoblastic Leukemia, Pediatric | NA | Status: NOT_YET_RECRUITING